SP Tulsian of sptulsian.com feels that Ranbaxy Laboratories may bounce back to Rs 360-370 in September series itself. “There is very limited risk of going down from here and Rs 320 seems to be a good support for the stock,†he adds.
first published: Sep 17, 2013 12:17 pm
A collection of the most-viewed Moneycontrol videos.
Sensex, Nifty resume rally after 2-day pause, financials shine bright | Closing Bell
Maran Govindasamy of Unifi Capital on Investment Insights from India’s Consumption Story
Nifty Bulls Likely To Tread With Caution With Eye On Axis Bank Q2 Earnings |Opening Bell Live
Live: Nifty slips below 25,200, LG Electronics shares down after blockbuster debut | Closing Bell
You are already a Moneycontrol Pro user.